865624-17-5 Usage
Uses
Used in Pharmaceutical Industry:
BENZENE, 1-(BROMOMETHYL)-3-CHLORO-5-NITROis used as an intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into complex organic molecules, contributing to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, BENZENE, 1-(BROMOMETHYL)-3-CHLORO-5-NITROserves as a key component in the production of various agrochemicals, such as pesticides and herbicides, due to its reactivity and potential to form stable and effective compounds.
Used in Industrial Chemical Production:
This benzene derivative is also employed in the manufacturing of industrial chemicals, where its unique structure allows for the creation of specialized compounds used in various applications, such as dyes, plastics, and coatings.
Safety Precautions:
It is crucial to handle BENZENE, 1-(BROMOMETHYL)-3-CHLORO-5-NITROwith care, as it is potentially harmful if it comes into contact with the skin, eyes, or if it is inhaled. Adhering to proper safety protocols during handling and storage is essential to prevent accidents or exposure.
Check Digit Verification of cas no
The CAS Registry Mumber 865624-17-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,5,6,2 and 4 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 865624-17:
(8*8)+(7*6)+(6*5)+(5*6)+(4*2)+(3*4)+(2*1)+(1*7)=195
195 % 10 = 5
So 865624-17-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H5BrClNO2/c8-4-5-1-6(9)3-7(2-5)10(11)12/h1-3H,4H2
865624-17-5Relevant articles and documents
DEOXYNOJIRIMYCIN DERIVATIVES AS GLUCOSIDASE INHIBITORS
-
Paragraph 0848, (2022/01/22)
The present invention relates to novel iminosugars and their use as glucosidase inhibitors. The present inventors discovered that certain deoxynojirimycin derivatives may be effective in inhibiting glucosidases. In particular, such deoxynojirimycin derivatives may be useful for treating a disease or condition in which inhibition of glucosidase may play an important role.
NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING AGONISTS OF THE THYROID RECEPTOR
-
Page/Page column 49, (2010/02/14)
The invention provides compounds of formula I or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides the use of such compounds in the treatment or prophylaxis of a condition mediated by a thyroid receptor. Formula (I) wherein R1, R2, n, Y, Y', R3, R4, W and R5 are as defined in the specification.
THYROID RECEPTOR AGONISTS
-
Page/Page column 66, (2010/02/14)
The invention provides compounds of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides the use of such compounds in the treatment or prophylaxis of a condition mediated by a thyroid receptor. Formula (I), wherein R1, R2, n, Y, Y', R3, R4, W and R5 are as defined in the specification.
